Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2620-2629
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2620
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2620
Table 1 Patient characteristics, n (%)
Parameter | Without rebleeding group (n = 87) | Rebleeding group (n = 81) | t/χ2 | P value |
Age (years) | 52.84 ± 8.15 | 54.15 ± 7.48 | 1.087 | 0.279 |
Gender (M/F) | 35 (40.23)/52 (59.77) | 37 (45.68)/44 (54.32) | 0.310 | 0.577 |
BMI (kg/m2) | 23.39 ± 1.31 | 23.65 ± 1.23 | 1.283 | 0.201 |
Smoking history (Yes/No) | 11 (12.64)/76 (87.36) | 10 (12.35)/71 (87.65) | 0.000 | 1.000 |
Alcohol history (Yes/No) | 20 (22.99)/67 (77.01) | 19 (23.46)/62 (76.54) | 0.000 | 1.000 |
Hypertension (Yes/No) | 9 (10.34)/78 (89.66) | 9 (11.11)/72 (88.89) | 0.000 | 1.000 |
Diabetes (Yes/No) | 7 (8.05)/80 (91.95) | 6 (7.41)/75 (92.59) | 0.000 | 1.000 |
Hyperlipidemia (Yes/No) | 8 (9.2)/79 (90.8) | 7 (8.64)/74 (91.36) | 0.000 | 1.000 |
Renal failure (Yes/No) | 8 (9.2)/79 (90.8) | 16 (19.75)/65 (80.25) | 3.005 | 0.083 |
Pneumonia (Yes/No) | 6 (6.9)/81 (93.1) | 12 (14.81)/69 (85.19) | 1.984 | 0.159 |
Septicemia (Yes/No) | 14 (16.09)/73 (83.91) | 14 (17.28)/67 (82.72) | 0.000 | 1.000 |
NSAID use (Yes/No) | 43 (49.43)/44 (50.57) | 50 (61.73%)/31 (38.27) | 2.095 | 0.148 |
Anticoagulant use (Yes/No) | 29 (33.33)/58 (66.67) | 37 (45.68)/44 (54.32) | 2.188 | 0.139 |
Table 2 Laboratory parameters, n (%)
Parameter | Without rebleeding group (n = 87) | Rebleeding group (n = 81) | t value | P value |
Hemoglobin (g/L) | 113.95 ± 11.44 | 109.14 ± 10.48 | 2.843 | 0.005 |
Platelet count (× 104/microliter) | 24.48 ± 8.15 | 22.97 ± 6.37 | 1.344 | 0.181 |
INR | 1.34 ± 0.18 | 1.48 ± 0.29 | 3.710 | < 0.001 |
Albumin (g/dL) | 3.91 ± 0.59 | 3.79 ± 0.67 | 1.168 | 0.244 |
Table 3 Endoscopic findings, n (%)
Parameter | Without rebleeding group (n = 87) | Rebleeding group (n = 81) | t/χ2 | P value |
Active bleeding (Yes/No) | 37 (42.53)/50 (57.47) | 53 (65.43)/28 (34.57) | 7.950 | 0.005 |
Average ulcer size (cm) | 1.19 ± 0.58 | 1.8 ± 0.65 | 6.348 | < 0.001 |
Number of ulcers (≤ 2/> 2) | 49 (56.32)/38 (43.68) | 30 (37.04)/51 (62.96) | 5.512 | 0.019 |
Ulcer location (gastric/duodenal) | 35 (40.23)/52 (59.77) | 38 (46.91)/43 (53.09) | 0.515 | 0.473 |
Table 4 Treatment and management, n (%)
Parameter | Without rebleeding group (n = 87) | Rebleeding group (n = 81) | χ2 | P value |
PPI therapy (Yes/No) | 85 (97.7)/2 (2.3) | 77 (95.06)/4 (4.94) | 0.255 | 0.613 |
Endoscopic therapy (Yes/No) | 60 (68.97)/27 (31.03) | 30 (37.04)/51 (62.96) | 15.933 | < 0.001 |
Blood transfusion (Yes/No) | 39 (44.83)/48 (55.17) | 53 (65.43)/28 (34.57) | 6.381 | 0.012 |
Table 5 Spearman correlation analysis
r value | R2 value | P value | |
Rockall score | 0.735 | 0.541 | < 0.001 |
Hemoglobin (g/L) | -0.215 | 0.046 | 0.005 |
INR | 0.281 | 0.079 | < 0.001 |
Average ulcer size (cm) | 0.443 | 0.197 | < 0.001 |
Renal failure (Yes/No) | 0.151 | 0.023 | 0.051 |
Active bleeding (Yes/No) | 0.229 | 0.053 | 0.003 |
Number of ulcers (≤ 2/>2) | -0.193 | 0.037 | 0.012 |
Endoscopic therapy (Yes/No) | -0.32 | 0.102 | < 0.001 |
Blood transfusion (Yes/No) | 0.207 | 0.043 | 0.007 |
Table 6 Receiver operating characteristic analysis
Sensitivities | Specificities | AUC | Youden index | |
Rockall score | 0.914 | 0.816 | 0.933 | 0.730 |
Hemoglobin (g/L) | 0.519 | 0.736 | 0.641 | 0.255 |
INR | 0.494 | 0.874 | 0.668 | 0.368 |
Average ulcer size (cm) | 0.864 | 0.552 | 0.752 | 0.416 |
Active bleeding (Yes/No) | 0.654 | 0.575 | 0.615 | 0.229 |
Number of ulcers (≤ 2/>2) | 0.63 | 0.563 | 0.596 | 0.193 |
Endoscopic therapy (Yes/No) | 0.63 | 0.69 | 0.66 | 0.32 |
Blood transfusion (Yes/No) | 0.654 | 0.552 | 0.603 | 0.206 |
Table 7 Logistic regression
Factor | Univariate regression | Multivariate regression | ||||||
OR | 95%CI | β | P value | OR | 95%CI | β | P value | |
Rockall score | 3.891 | 2.729-6.057 | 1.359 | < 0.001 | 1.134 | 1.106-1.164 | 0.126 | 0 |
Hemoglobin (g/L) | 0.96 | 0.932-0.988 | -0.04 | 0.007 | 0.998 | 0.994-1.002 | -0.002 | 0.317 |
INR | 11.647 | 3.092-48.723 | 2.455 | < 0.001 | 1.142 | 0.926-1.409 | 0.133 | 0.214 |
Average ulcer size (cm) | 5.013 | 2.826-9.577 | 1.612 | < 0.001 | 1.156 | 1.069-1.25 | 0.145 | 0 |
Active bleeding (Yes/No) | 2.558 | 1.378-4.822 | 0.939 | 0.003 | 1.117 | 1.007-1.24 | 0.111 | 0.036 |
Number of ulcers (≤ 2/>2) | 0.456 | 0.244-0.843 | -0.785 | 0.013 | 0.91 | 0.824-1.006 | -0.094 | 0.065 |
Endoscopic therapy (Yes/No) | 0.265 | 0.138-0.497 | -1.329 | < 0.001 | 0.908 | 0.817-1.01 | -0.096 | 0.075 |
Blood transfusion (Yes/No) | 2.33 | 1.257-4.382 | 0.846 | 0.008 | 1.055 | 0.955-1.166 | 0.054 | 0.29 |
- Citation: Han DP, Gou CQ, Ren XM. Predictive utility of the Rockall scoring system in patients suffering from acute nonvariceal upper gastrointestinal hemorrhage. World J Gastrointest Surg 2024; 16(8): 2620-2629
- URL: https://www.wjgnet.com/1948-9366/full/v16/i8/2620.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i8.2620